| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016072 | HBV | ENSG00000149124.11 | protein_coding | GLYAT | No | No | 10249 | Q6IB77 |
| TVIS10026571 | HBV | ENSG00000149124.11 | protein_coding | GLYAT | No | No | 10249 | Q6IB77 |
| TVIS20018489 | HPV | ENSG00000149124.11 | protein_coding | GLYAT | No | No | 10249 | Q6IB77 |
| TVIS20050067 | HPV | ENSG00000149124.11 | protein_coding | GLYAT | No | No | 10249 | Q6IB77 |
| TVIS44040815 | HTLV-1 | ENSG00000149124.11 | protein_coding | GLYAT | No | No | 10249 | Q6IB77 |
| TVIS44040899 | HTLV-1 | ENSG00000149124.11 | protein_coding | GLYAT | No | No | 10249 | Q6IB77 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GLYAT |
|---|---|
| DrugBank ID | DB00145 |
| Drug Name | Glycine |
| Target ID | BE0002305 |
| UniProt ID | Q6IB77 |
| Regulation Type | substrate |
| PubMed IDs | 17146584; 17143481 |
| Citations | Narasipura SD, Ren P, Dyavaiah M, Auger I, Chaturvedi V, Chaturvedi S: An efficient method for homologous gene reconstitution in Cryptococcus gattii using URA5 auxotrophic marker. Mycopathologia. 2006 Dec;162(6):401-9.@@Zhou CX, Gao Y: Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis. Oncol Rep. 2007 Jan;17(1):73-9. |
| Groups | Approved; Nutraceutical; Vet_approved |
| Direct Classification | Alpha amino acids |
| SMILES | NCC(O)=O |
| Pathways | gamma-Glutamyltranspeptidase Deficiency; Lesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Molybdenum Cofactor Deficiency; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; gamma-Glutamyltransferase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); L-Arginine:Glycine Amidinotransferase Deficiency; Hyperinsulinism-Hyperammonemia Syndrome; Congenital Bile Acid Synthesis Defect Type II; Porphyrin Metabolism; Prolidase Deficiency (PD); Glycine and Serine Metabolism; Carnitine Synthesis; Adenosine Deaminase Deficiency; Methionine Metabolism; Bile Acid Biosynthesis; Hyperprolinemia Type I; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; 27-Hydroxylase Deficiency; Sarcosine Oncometabolite Pathway; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Ammonia Recycling |
| PharmGKB | PA449789 |
| ChEMBL | CHEMBL773 |
